{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:23:03Z","timestamp":1790882583195,"version":"4.1.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T00:00:00Z","timestamp":1483574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/nrgastro.2016.195","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T05:09:42Z","timestamp":1483592982000},"page":"230-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":163,"title":["Population screening and treatment of Helicobacter pylori infection"],"prefix":"10.1038","volume":"14","author":[{"given":"Anthony","family":"O'Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm A.","family":"O'Morain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"issue":"Suppl. 2","key":"BFnrgastro2016195_CR1","first-page":"33","volume":"9","author":"RE Pounder","year":"1995","unstructured":"Pounder, R. E. & Ng, D. The prevalence of Helicobacter pylori infection in different countries. Aliment. Pharmacol. Ther. 9 (Suppl. 2), 33\u201339 (1995).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016195_CR2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/apt.13474","volume":"43","author":"SE Roberts","year":"2016","unstructured":"Roberts, S. E. et al. Review article: the prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe. Aliment. Pharmacol. Ther. 43, 334\u2013345 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016195_CR3","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/0016-5085(91)90644-Z","volume":"100","author":"DY Graham","year":"1991","unstructured":"Graham, D. Y. et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Gastroenterology 100, 1495\u20131501 (1991).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016195_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/apt.12293","volume":"37","author":"TL Yan","year":"2013","unstructured":"Yan, T. L., Hu, Q. D., Zhang, Q., Li, Y. M. & Liang, T. B. National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index. Aliment. Pharmacol. Ther. 37, 963\u2013968 (2013).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016195_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1186\/1471-2458-14-915","volume":"14","author":"RK Baingana","year":"2014","unstructured":"Baingana, R. K., Kiboko Enyaru, J. & Davidsson, L. Helicobacter pylori infection in pregnant women in four districts of Uganda: role of geographic location, education and water sources. BMC Public Health 14, 915 (2014).","journal-title":"BMC Public Health"},{"key":"BFnrgastro2016195_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/1756-0500-6-346","volume":"6","author":"B Mathewos","year":"2013","unstructured":"Mathewos, B., Moges, B. & Dagnew, M. Seroprevalence and trend of Helicobacter pylori infection in Gondar University Hospital among dyspeptic patients, Gondar, North West Ethiopia. BMC Res. Notes 6, 346 (2013).","journal-title":"BMC Res. Notes"},{"key":"BFnrgastro2016195_CR7","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.3748\/wjg.v20.i13.3635","volume":"20","author":"M Zhang","year":"2014","unstructured":"Zhang, M. et al. Seroepidemiology of Helicobacter pylori infection in elderly people in the Beijing region, China. World J. Gastroenterol. 20, 3635\u20133639 (2014).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016195_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/hel.12110","volume":"19","author":"J Ueda","year":"2014","unstructured":"Ueda, J. et al. Prevalence of Helicobacter pylori infection by birth year and geographic area in Japan. Helicobacter 19, 105\u2013110 (2014).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1590\/1806-9282.60.04.008","volume":"60","author":"GF Poveda","year":"2014","unstructured":"Poveda, G. F., Carrillo, K. S., Monje, M. E., Cruz, C. A. & Cancino, A. G. Helicobacter pylori infection and gastrointestinal symptoms on Chilean pregnant women. Rev. Assoc. Med. Bras. (1992) 60, 306\u2013310 (2014).","journal-title":"Rev. Assoc. Med. Bras. (1992)"},{"key":"BFnrgastro2016195_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/hel.12137","volume":"19","author":"S Sivapalasingam","year":"2014","unstructured":"Sivapalasingam, S. et al. Recurrence of Helicobacter pylori infection in Bolivian children and adults after a population-based \u201cscreen and treat\u201d strategy. Helicobacter 19, 343\u2013348 (2014).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.advms.2014.01.003","volume":"59","author":"W Laszewicz","year":"2014","unstructured":"Laszewicz, W., Iwanczak, F. & Iwanczak, B. Seroprevalence of Helicobacter pylori infection in Polish children and adults depending on socioeconomic status and living conditions. Adv. Med. Sci. 59, 147\u2013150 (2014).","journal-title":"Adv. Med. Sci."},{"key":"BFnrgastro2016195_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1186\/1471-2458-13-1215","volume":"13","author":"N Ozaydin","year":"2013","unstructured":"Ozaydin, N., Turkyilmaz, S. A. & Cali, S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the 13C-Urea breath test. BMC Public Health 13, 1215 (2013).","journal-title":"BMC Public Health"},{"key":"BFnrgastro2016195_CR13","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3109\/00365521.2013.799221","volume":"48","author":"M van Blankenstein","year":"2013","unstructured":"van Blankenstein, M., van Vuuren, A. J., Looman, C. W., Ouwendijk, M. & Kuipers, E. J. The prevalence of Helicobacter pylori infection in the Netherlands. Scand. J. Gastroenterol. 48, 794\u2013800 (2013).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.dld.2012.11.009","volume":"45","author":"J Bastos","year":"2013","unstructured":"Bastos, J. et al. Prevalence, incidence and risk factors for Helicobacter pylori infection in a cohort of Portuguese adolescents (EpiTeen). Dig. Liver Dis. 45, 290\u2013295 (2013).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro2016195_CR15","first-page":"e182","volume":"59","author":"A Sethi","year":"2013","unstructured":"Sethi, A., Chaudhuri, M., Kelly, L. & Hopman, W. Prevalence of Helicobacter pylori in a First Nations population in northwestern Ontario. Can. Fam. Physician 59, e182\u2013e187 (2013).","journal-title":"Can. Fam. Physician"},{"key":"BFnrgastro2016195_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.29074\/ascls.25.2.102","volume":"25","author":"T Patterson","year":"2012","unstructured":"Patterson, T., Straten, E. & Jimenez, S. The prevalence of Helicobacter pylori antibody in different age groups in Central Texas. Clin. Lab. Sci. 25, 102\u2013106 (2012).","journal-title":"Clin. Lab. Sci."},{"key":"BFnrgastro2016195_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.clinre.2013.02.003","volume":"37","author":"DA Benajah","year":"2013","unstructured":"Benajah, D. A. et al. Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco). Clin. Res. Hepatol. Gastroenterol. 37, 519\u2013526 (2013).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"BFnrgastro2016195_CR18","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/j.1440-1746.2011.06726.x","volume":"26","author":"N Pandeya","year":"2011","unstructured":"Pandeya, N. & Whiteman, D. C. Prevalence and determinants of Helicobacter pylori sero-positivity in the Australian adult community. J. Gastroenterol. Hepatol. 26, 1283\u20131289 (2011).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016195_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/01.EPX.0000427043.99834.a4","volume":"88","author":"MI Hanafi","year":"2013","unstructured":"Hanafi, M. I. & Mohamed, A. M. Helicobacter pylori infection: seroprevalence and predictors among healthy individuals in Al Madinah, Saudi Arabia. J. Egypt Public Health Assoc. 88, 40\u201345 (2013).","journal-title":"J. Egypt Public Health Assoc."},{"key":"BFnrgastro2016195_CR20","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1017\/S0950268811002081","volume":"140","author":"K Muhsen","year":"2012","unstructured":"Muhsen, K., Cohen, D., Spungin-Bialik, A. & Shohat, T. Seroprevalence, correlates and trends of Helicobacter pylori infection in the Israeli population. Epidemiol. Infect. 140, 1207\u20131214 (2012).","journal-title":"Epidemiol. Infect."},{"key":"BFnrgastro2016195_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87\u2013108 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"BFnrgastro2016195_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0140-6736(75)90498-5","volume":"306","author":"P Correa","year":"1975","unstructured":"Correa, P., Haenszel, W., Cuello, C., Tannenbaum, S. & Archer, M. A model for gastric cancer epidemiology. Lancet 306, 58\u201360 (1975).","journal-title":"Lancet"},{"key":"BFnrgastro2016195_CR23","first-page":"437","volume":"2","author":"P Correa","year":"1983","unstructured":"Correa, P. The gastric precancerous process. Cancer Surv. 2, 437\u2013450 (1983).","journal-title":"Cancer Surv."},{"key":"BFnrgastro2016195_CR24","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/jnci\/57.5.1027","volume":"57","author":"P Correa","year":"1976","unstructured":"Correa, P. et al. Gastric cancer in Colombia III: natural history of precursor lesions. J. Natl Cancer Inst. 57, 1027\u20131035 (1976).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2016195_CR25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ijc.2910460410","volume":"46","author":"D Forman","year":"1990","unstructured":"Forman, D. et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int. J. Cancer 46, 608\u2013611 (1990).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro2016195_CR26","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/1097-0142(19901215)66:12<2569::AID-CNCR2820661220>3.0.CO;2-I","volume":"66","author":"P Correa","year":"1990","unstructured":"Correa, P. et al. Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks. Cancer 66, 2569\u20132574 (1990).","journal-title":"Cancer"},{"key":"BFnrgastro2016195_CR27","doi-asserted-by":"crossref","unstructured":"The Eurogast Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 34, 1672\u20131676 (1993).","DOI":"10.1136\/gut.34.12.1672"},{"issue":"3","key":"BFnrgastro2016195_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/gut.49.3.347","volume":"49","author":"Helicobacter and Cancer Collaborati","year":"2001","unstructured":"Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49, 347\u2013353 (2001).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12664-010-0024-1","volume":"29","author":"UC Ghoshal","year":"2010","unstructured":"Ghoshal, U. C., Chaturvedi, R. & Correa, P. The enigma of Helicobacter pylori infection and gastric cancer. Indian J. Gastroenterol. 29, 95\u2013100 (2010).","journal-title":"Indian J. Gastroenterol."},{"key":"BFnrgastro2016195_CR30","unstructured":"International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks Hum. 61, 177\u2013241 (1994)."},{"key":"BFnrgastro2016195_CR31","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1001\/jama.282.23.2240","volume":"282","author":"J Parsonnet","year":"1999","unstructured":"Parsonnet, J., Shmuely, H. & Haggerty, T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 282, 2240\u20132245 (1999).","journal-title":"JAMA"},{"key":"BFnrgastro2016195_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1523-5378.2009.00692.x","volume":"14","author":"A Janzon","year":"2009","unstructured":"Janzon, A. et al. Presence of high numbers of transcriptionally active Helicobacter pylori in vomitus from Bangladeshi patients suffering from acute gastroenteritis. Helicobacter 14, 237\u2013247 (2009).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR33","first-page":"1759","volume":"122","author":"DH Zhang","year":"2009","unstructured":"Zhang, D. H. et al. Recent changes in the prevalence of Helicobacter pylori infection among children and adults in high- or low-incidence regions of gastric cancer in China. Chin. Med. J. (Engl.) 122, 1759\u20131763 (2009).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"BFnrgastro2016195_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/qjmed\/95.8.519","volume":"95","author":"RF Harvey","year":"2002","unstructured":"Harvey, R. F. et al. Relationship between the birth cohort pattern of Helicobacter pylori infection and the epidemiology of duodenal ulcer. QJM 95, 519\u2013525 (2002).","journal-title":"QJM"},{"key":"BFnrgastro2016195_CR35","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s10552-009-9397-9","volume":"20","author":"JM Yeh","year":"2009","unstructured":"Yeh, J. M., Goldie, S. J., Kuntz, K. M. & Ezzati, M. Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections. Cancer Causes Control 20, 2021\u20132029 (2009).","journal-title":"Cancer Causes Control"},{"issue":"Suppl. 1","key":"BFnrgastro2016195_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-5378.2010.00779.x","volume":"15","author":"AC Ford","year":"2010","unstructured":"Ford, A. C. & Axon, A. T. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 15 (Suppl. 1), 1\u20136 (2010).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.canep.2009.09.006","volume":"33","author":"XC Wu","year":"2009","unstructured":"Wu, X. C., Andrews, P., Chen, V. W. & Groves, F. D. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians\/Pacific Islanders in the United States: anatomic site and histology differences. Cancer Epidemiol. 33, 337\u2013346 (2009).","journal-title":"Cancer Epidemiol."},{"key":"BFnrgastro2016195_CR38","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1056\/NEJM199405053301803","volume":"330","author":"J Parsonnet","year":"1994","unstructured":"Parsonnet, J. et al. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330, 1267\u20131271 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016195_CR39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/2050640615612934","volume":"4","author":"J Moleiro","year":"2016","unstructured":"Moleiro, J., Ferreira, S., Lage, P. & Dias Pereira, A. Gastric malt lymphoma: analysis of a series of consecutive patients over 20 years. United European Gastroenterol. J. 4, 395\u2013402 (2016).","journal-title":"United European Gastroenterol. J."},{"key":"BFnrgastro2016195_CR40","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 272, 65\u201369 (1994).","DOI":"10.1001\/jama.272.1.65"},{"key":"BFnrgastro2016195_CR41","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1111\/j.1572-0241.2004.40014.x","volume":"99","author":"AC Ford","year":"2004","unstructured":"Ford, A. C., Delaney, B. C., Forman, D. & Moayyedi, P. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am. J. Gastroenterol. 99, 1833\u20131855 (2004).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR42","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/j.1572-0241.2000.2126_1.x","volume":"95","author":"P Moayyedi","year":"2000","unstructured":"Moayyedi, P. et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Am. J. Gastroenterol. 95, 1448\u20131455 (2000).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR43","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1111\/j.1572-0241.2003.08724.x","volume":"98","author":"P Moayyedi","year":"2003","unstructured":"Moayyedi, P., Deeks, J., Talley, N. J., Delaney, B. C. & Forman, D. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in non-ulcer dyspepsia: resolving the discrepancy between systematic reviews. Am. J. Gastroenterol. 98, 2621\u20132626 (2003).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR44","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/bmj.321.7262.659","volume":"321","author":"P Moayyedi","year":"2000","unstructured":"Moayyedi, P. et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. BMJ 321, 659\u2013664 (2000).","journal-title":"BMJ"},{"key":"BFnrgastro2016195_CR45","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/gerona\/61.11.1144","volume":"61","author":"N Salles","year":"2006","unstructured":"Salles, N. et al. Effects of Helicobacter pylori infection on gut appetite peptide (leptin, ghrelin) expression in elderly inpatients. J. Gerontol. A Biol. Sci. Med. Sci. 61, 1144\u20131150 (2006).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"BFnrgastro2016195_CR46","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3324\/haematol.2008.005348","volume":"94","author":"DM Arnold","year":"2009","unstructured":"Arnold, D. M. et al. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica 94, 850\u2013856 (2009).","journal-title":"Haematologica"},{"key":"BFnrgastro2016195_CR47","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3109\/00365521003663670","volume":"45","author":"W Yuan","year":"2010","unstructured":"Yuan, W. et al. Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials. Scand. J. Gastroenterol. 45, 665\u2013676 (2010).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/gut.43.3.327","volume":"43","author":"H El-Serag","year":"1998","unstructured":"El-Serag, H. & Sonnenberg, A. Opposing time trends of peptic ulcer and reflux disease. Gut 43, 327\u2013333 (1998).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR49","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren, J., Bergstrom, R., Lindgren, A. & Nyren, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340, 825\u2013831 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016195_CR50","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1038\/ajg.2011.326","volume":"106","author":"J Ronkainen","year":"2011","unstructured":"Ronkainen, J. et al. Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study. Am. J. Gastroenterol. 106, 1946\u20131952 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR51","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1093\/annonc\/mds181","volume":"23","author":"AP Thrift","year":"2012","unstructured":"Thrift, A. P. & Whiteman, D. C. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann. Oncol. 23, 3155\u20133162 (2012).","journal-title":"Ann. Oncol."},{"key":"BFnrgastro2016195_CR52","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/bmj.326.7392.737","volume":"326","author":"A Raghunath","year":"2003","unstructured":"Raghunath, A., Hungin, A. P. S., Wooff, D. & Childs, S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 326, 736\u2013739 (2003).","journal-title":"BMJ"},{"key":"BFnrgastro2016195_CR53","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/S0016-5085(97)70024-6","volume":"112","author":"J Labenz","year":"1997","unstructured":"Labenz, J. et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112, 1442\u20131447 (1997).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016195_CR54","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1053\/gast.2001.29332","volume":"121","author":"P Moayyedi","year":"2001","unstructured":"Moayyedi, P. et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 121, 1120\u20131126 (2001).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016195_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/gut.53.1.12","volume":"53","author":"EJ Kuipers","year":"2004","unstructured":"Kuipers, E. J. et al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 53, 12\u201320 (2004).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/00365521.2011.648955","volume":"47","author":"AM Saad","year":"2012","unstructured":"Saad, A. M., Choudhary, A. & Bechtold, M. L. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand. J. Gastroenterol. 47, 129\u2013135 (2012).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR57","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/ijc.26242","volume":"130","author":"AP Thrift","year":"2012","unstructured":"Thrift, A. P. et al. Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study. Int. J. Cancer 130, 2407\u20132416 (2012).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro2016195_CR58","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/jnci\/djh057","volume":"96","author":"W Ye","year":"2004","unstructured":"Ye, W. et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J. Natl Cancer Inst. 96, 388\u2013396 (2004).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2016195_CR59","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cgh.2007.08.010","volume":"5","author":"T Rokkas","year":"2007","unstructured":"Rokkas, T., Pistiolas, D., Sechopoulos, P., Robotis, I. & Margantinis, G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin. Gastroenterol. Hepatol. 5, 1413\u20131417.e2 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016195_CR60","doi-asserted-by":"publisher","first-page":"17635","DOI":"10.3748\/wjg.v20.i46.17635","volume":"20","author":"E Lionetti","year":"2014","unstructured":"Lionetti, E. et al. Helicobacter pylori infection and atopic diseases: is there a relationship? A systematic review and meta-analysis. World J. Gastroenterol. 20, 17635\u201317647 (2014).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016195_CR61","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1086\/590158","volume":"198","author":"Y Chen","year":"2008","unstructured":"Chen, Y. & Blaser, M. J. Helicobacter pylori colonization is inversely associated with childhood asthma. J. Infect. Dis. 198, 553\u2013560 (2008).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2016195_CR62","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/archinte.167.8.821","volume":"167","author":"Y Chen","year":"2007","unstructured":"Chen, Y. & Blaser, M. J. Inverse associations of Helicobacter pylori with asthma and allergy. Arch. Intern. Med. 167, 821\u2013827 (2007).","journal-title":"Arch. Intern. Med."},{"key":"BFnrgastro2016195_CR63","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/apt.13560","volume":"43","author":"U von Arnim","year":"2016","unstructured":"von Arnim, U. et al. Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis. Aliment. Pharmacol. Ther. 43, 825\u2013830 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016195_CR64","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/hel.12065","volume":"18","author":"OA Paoluzi","year":"2013","unstructured":"Paoluzi, O. A. et al. Helicobacter pylori infection associates with a mucosal downregulation of ghrelin, negative regulator of Th1-cell responses. Helicobacter 18, 406\u2013412 (2013).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR65","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s00535-009-0120-0","volume":"44","author":"J Kawashima","year":"2009","unstructured":"Kawashima, J. et al. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J. Gastroenterol. 44, 1046\u20131054 (2009).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2016195_CR66","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1365-2036.2011.04610.x","volume":"33","author":"JA Lane","year":"2011","unstructured":"Lane, J. A. et al. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment. Pharmacol. Ther. 33, 922\u2013929 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016195_CR67","unstructured":"IARC Helicobacter pylori Working Group. Helicobacter pylori eradication as a strategy for preventing gastric cancer. IARC http:\/\/www.iarc.fr\/en\/publications\/pdfs-online\/wrk\/wrk8\/index.php (2014)."},{"key":"BFnrgastro2016195_CR68","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1136\/gut.30.8.1058","volume":"30","author":"CAM McNulty","year":"1989","unstructured":"McNulty, C. A. M., Dent, J. C., Uff, J. S., Gear, M. W. L. & Wilkinson, S. P. Detection of Campylobacter pylori by the biopsy urease test: an assessment in 1445 patients. Gut 30, 1058\u20131062 (1989).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR69","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/jcp.41.3.355-b","volume":"41","author":"D Vaira","year":"1988","unstructured":"Vaira, D., Holton, J., Cairns, S. R., Falzon, M. & Salmon, P. R. Four hour rapid urease test (RUT) for detecting Campylobacter pylori: is it reliable enough to start treatment? J. Clin. Pathol. 41, 355\u2013356 (1988).","journal-title":"J. Clin. Pathol."},{"key":"BFnrgastro2016195_CR70","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.3748\/wjg.v17.i41.4596","volume":"17","author":"M Rugge","year":"2011","unstructured":"Rugge, M. et al. Operative link for gastritis assessment versus operative link on intestinal metaplasia assessment. World J. Gastroenterol. 17, 4596\u20134601 (2011).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016195_CR71","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/gut.27.6.642","volume":"27","author":"BJ Rathbone","year":"1986","unstructured":"Rathbone, B. J. et al. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut 27, 642\u2013647 (1986).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/gut.36.1.12","volume":"36","author":"RPH Logan","year":"1995","unstructured":"Logan, R. P. H. et al. Changes in the intra-gastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 36, 12\u201316 (1995).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/00365520600863720","volume":"42","author":"P Sipponen","year":"2007","unstructured":"Sipponen, P. & Graham, D. Y. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand. J. Gastroenterol. 42, 2\u201310 (2007).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR74","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.dld.2008.02.028","volume":"40","author":"F di Mario","year":"2008","unstructured":"di Mario, F. & Cavallaro, L. G. Non-invasive tests in gastric diseases. Dig. Liver Dis. 40, 523\u2013530 (2008).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro2016195_CR75","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/sj.bjc.6600877","volume":"88","author":"N Broutet","year":"2003","unstructured":"Broutet, N., Plebani, M., Sakarovitch, C., Sipponen, P. & Megraud, F. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br. J. Cancer 88, 1239\u20131247 (2003).","journal-title":"Br. J. Cancer"},{"key":"BFnrgastro2016195_CR76","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/hel.12030","volume":"18","author":"C Burucoa","year":"2013","unstructured":"Burucoa, C. et al. Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter 18, 169\u2013179 (2013).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR77","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3748\/wjg.v21.i4.1305","volume":"21","author":"M Ferwana","year":"2015","unstructured":"Ferwana, M. et al. Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis. World J. Gastroenterol. 21, 1305\u20131314 (2015).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016195_CR78","first-page":"915","volume":"3","author":"RPH Logan","year":"1991","unstructured":"Logan, R. P. H. et al. The European 13 C-urea breath test for the detection of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 3, 915\u2013921 (1991).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016195_CR79","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/j.1572-0241.2006.00668.x","volume":"101","author":"JP Gisbert","year":"2006","unstructured":"Gisbert, J. P., de la Morena, F. & Abraira, V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am. J. Gastroenterol. 101, 1921\u20131930 (2006).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR80","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/00042737-200012060-00009","volume":"12","author":"F Megraud","year":"2000","unstructured":"Megraud, F. et al. Comparison of tests for assessment of Helicobacter pylori eradication: results of a multi-centre study using centralised testing facility. Eur. J. Gastroenterol. Hepatol. 12, 629\u2013633 (2000).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016195_CR81","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1128\/JCM.36.9.2772-2774.1998","volume":"36","author":"A Makristathis","year":"1998","unstructured":"Makristathis, A. et al. Detection of Helicobacter pylori in stool specimens by PCR and antigen enzyme immunoassay. J. Clin. Microbiol. 36, 2772\u20132774 (1998).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrgastro2016195_CR82","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner, P. et al. Management of Helicobacter pylori infection: the Maastricht IV\/ Florence Consensus Report. Gut 61, 646\u2013664 (2012).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR83","first-page":"305","volume":"95","author":"KP Cullen","year":"2002","unstructured":"Cullen, K. P., Broderick, B. M., Jayaram, J., Flynn, B. & O'Connor, H. J. Evaluation of the Helicobacter pylori stool antigen (HpSA) test in routine clinical practice \u2014 is it patient-friendly? Ir. Med. J. 95, 305\u2013306 (2002).","journal-title":"Ir. Med. J."},{"key":"BFnrgastro2016195_CR84","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/00042737-199409000-00004","volume":"6","author":"F Bazzoli","year":"1994","unstructured":"Bazzoli, F. et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 6, 773\u2013777 (1994).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016195_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/hel.12287","volume":"21","author":"DY Graham","year":"2016","unstructured":"Graham, D. Y. Hp-normogram (normo-graham) for assessing the outcome of H. pylori therapy: effect of resistance, duration, and CYP2C19 genotype. Helicobacter 21, 85\u201390 (2016).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR86","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung, I. et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment. Pharmacol. Ther. 43, 514\u2013533 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"Suppl. 1","key":"BFnrgastro2016195_CR87","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/hel.12258","volume":"20","author":"A O'Connor","year":"2015","unstructured":"O'Connor, A., Gisbert, J. P., O'Morain, C. & Ladas, S. Treatment of Helicobacter pylori infection 2015. Helicobacter 20 (Suppl. 1), 54\u201361 (2015).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR88","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1136\/gutjnl-2015-311304","volume":"65","author":"K Murakami","year":"2016","unstructured":"Murakami, K. et al. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut 65, 1439\u20131446 (2016).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR89","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/gut.2003.037499","volume":"53","author":"DY Graham","year":"2004","unstructured":"Graham, D. Y. et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut 53, 1235\u20131243 (2004).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR90","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","volume":"386","author":"M Zeng","year":"2015","unstructured":"Zeng, M. et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 386, 1457\u20131464 (2015).","journal-title":"Lancet"},{"key":"BFnrgastro2016195_CR91","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/0140-6736(93)91473-Y","volume":"342","author":"EJ Kuipers","year":"1993","unstructured":"Kuipers, E. J. et al. Seroconversion for Helicobacter pylori. Lancet 342, 328\u2013331 (1993).","journal-title":"Lancet"},{"key":"BFnrgastro2016195_CR92","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/infdis\/168.1.219","volume":"168","author":"N Banatvala","year":"1993","unstructured":"Banatvala, N. et al. The cohort effect and Helicobacter pylori. J. Infect. Dis. 168, 219\u2013221 (1993).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2016195_CR93","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00042737-200012050-00002","volume":"12","author":"HM Nabwera","year":"2000","unstructured":"Nabwera, H. M., Nguyen-Van-Tam, J. S., Logan, R. F. A. & Logan, R. P. H. Prevalence of Helicobacter pylori infection in Kenyan schoolchildren aged 3\u201315 years and risk factors for infection. Eur. J. Gastroenterol. Hepatol. 12, 483\u2013487 (2000).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016195_CR94","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/j.1572-0241.2007.01080.x","volume":"102","author":"AC Ford","year":"2007","unstructured":"Ford, A. C. et al. Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study. Am. J. Gastroenterol. 102, 957\u2013965 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR95","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.3928\/00904481-20151112-09","volume":"44","author":"SG Yallapragada","year":"2015","unstructured":"Yallapragada, S. G., Nash, C. B. & Robinson, D. T. Early-life exposure to antibiotics, alterations in the intestinal microbiome, and risk of metabolic disease in children and adults. Pediatr. Ann. 44, e265\u2013e269 (2015).","journal-title":"Pediatr. Ann."},{"issue":"Suppl. 2","key":"BFnrgastro2016195_CR96","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1523-5378.2007.00563.x","volume":"12","author":"T Rokkas","year":"2007","unstructured":"Rokkas, T., Pistiolas, D., Sechopoulos, P., Robotis, I. & Margantinis, G. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 12 (Suppl. 2), 32\u201338 (2007).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR97","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000280318","volume":"83","author":"J Wang","year":"2011","unstructured":"Wang, J. et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 83, 253\u2013260 (2011).","journal-title":"Digestion"},{"key":"BFnrgastro2016195_CR98","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.3748\/wjg.v20.i19.5903","volume":"20","author":"YJ Kong","year":"2014","unstructured":"Kong, Y. J., Yi, H. G., Dai, J. C. & Wei, M. X. Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis. World J. Gastroenterol. 20, 5903\u20135911 (2014).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016195_CR99","first-page":"236","volume":"3","author":"K Satoh","year":"1998","unstructured":"Satoh, K., Kimura, K., Takimoto, T. & Kihira, K. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 3, 236\u2013240 (1998).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR100","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/gutjnl-2012-302240","volume":"62","author":"YC Lee","year":"2013","unstructured":"Lee, Y. C. et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 62, 676\u2013682 (2013).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR101","first-page":"11","volume":"116","author":"L Zhou","year":"2003","unstructured":"Zhou, L. et al. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin. Med. J. (Engl.) 116, 11\u201314 (2003).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"BFnrgastro2016195_CR102","doi-asserted-by":"publisher","first-page":"i13","DOI":"10.1136\/gut.2004.041533","volume":"54","author":"P Malfertheiner","year":"2005","unstructured":"Malfertheiner, P. & Peitz, U. The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia. Gut 54, i13\u2013i20 (2005).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR103","first-page":"1512","volume":"60","author":"N Shimizu","year":"2000","unstructured":"Shimizu, N. et al. Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res. 60, 1512\u20131514 (2000).","journal-title":"Cancer Res."},{"key":"BFnrgastro2016195_CR104","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1349-7006.2003.tb01426.x","volume":"94","author":"K Nozaki","year":"2003","unstructured":"Nozaki, K. et al. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci. 94, 235\u2013239 (2003).","journal-title":"Cancer Sci."},{"key":"BFnrgastro2016195_CR105","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","volume":"372","author":"K Fukase","year":"2008","unstructured":"Fukase, K. et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372, 392\u2013397 (2008).","journal-title":"Lancet"},{"key":"BFnrgastro2016195_CR106","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cgh.2013.09.057","volume":"12","author":"J Choi","year":"2014","unstructured":"Choi, J. et al. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin. Gastroenterol. Hepatol. 12, 793\u2013800 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016195_CR107","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/hel.12146","volume":"19","author":"SB Yoon","year":"2014","unstructured":"Yoon, S. B., Park, J. M., Lim, C. H., Cho, Y. K. & Choi, M. G. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter 19, 243\u2013248 (2014).","journal-title":"Helicobacter"},{"key":"BFnrgastro2016195_CR108","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/jnci\/djj264","volume":"98","author":"WC You","year":"2006","unstructured":"You, W. C. et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J. Natl Cancer Inst. 98, 974\u2013983 (2006).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2016195_CR109","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/jnci\/djs003","volume":"104","author":"JL Ma","year":"2012","unstructured":"Ma, J. L. et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality J. Natl Cancer Inst. 104, 488\u2013492 (2012).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2016195_CR110","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/jnci\/92.23.1881","volume":"92","author":"P Correa","year":"2000","unstructured":"Correa, P. et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J. Natl Cancer Inst. 92, 1881\u20131888 (2000).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2016195_CR111","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1136\/gut.2003.034629","volume":"53","author":"WK Leung","year":"2004","unstructured":"Leung, W. K. et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 53, 1244\u20131249 (2004).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1053\/gast.2000.8550","volume":"119","author":"JJY Sung","year":"2000","unstructured":"Sung, J. J. Y. et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 119, 7\u201314 (2000).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016195_CR113","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jama.291.2.187","volume":"291","author":"BCY Wong","year":"2004","unstructured":"Wong, B. C. Y. et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291, 187\u2013194 (2004).","journal-title":"JAMA"},{"key":"BFnrgastro2016195_CR114","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gutjnl-2011-300154","volume":"61","author":"BCY Wong","year":"2012","unstructured":"Wong, B. C. Y. et al. Effects of selective COX-2 inhibition and Helicobacter pylori eradication on precancerous gastric lesions. Gut 61, 812\u2013818 (2012).","journal-title":"Gut"},{"issue":"Suppl. 2","key":"BFnrgastro2016195_CR115","first-page":"A4","volume":"128","author":"D Saito","year":"2005","unstructured":"Saito, D. et al. Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the Japanese intervention trial (JITHP-Study): a randomized multi-center trial. Gastroenterology 128 (Suppl. 2), A4 (2005).","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"BFnrgastro2016195_CR116","first-page":"A233","volume":"134","author":"L Zhou","year":"2008","unstructured":"Zhou, L. Ten-year follow-up study on the incidence of gastric cancer and the pathological changes of gastric mucosa after H. pylori eradication in China. Gastroenterology 134 (Suppl. 1), A233 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016195_CR117","doi-asserted-by":"publisher","first-page":"g3174","DOI":"10.1136\/bmj.g3174","volume":"348","author":"AC Ford","year":"2014","unstructured":"Ford, A. C., Forman, D., Hunt, R. H., Yuan, Y. & Moayyedi, P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 348, g3174 (2014).","journal-title":"BMJ"},{"key":"BFnrgastro2016195_CR118","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1470-2045(08)70072-X","volume":"9","author":"WK Leung","year":"2008","unstructured":"Leung, W. K. et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 9, 279\u2013287 (2008).","journal-title":"Lancet Oncol."},{"key":"BFnrgastro2016195_CR119","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.cgh.2009.03.031","volume":"7","author":"N Vakil","year":"2009","unstructured":"Vakil, N. et al. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin. Gastroenterol. Hepatol. 7, 756\u2013761 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016195_CR120","unstructured":"Wilson, J. M. & Jungner, G. Principles and practice of screening for disease. WHO http:\/\/apps.who.int\/iris\/bitstream\/10665\/37650\/17\/WHO_PHP_34.pdf (1968)."},{"key":"BFnrgastro2016195_CR121","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1052-5157(18)30322-2","volume":"7","author":"P Moayyedi","year":"1997","unstructured":"Moayyedi, P. & Dixon, M. F. Significance of Helicobacter pylori infection and gastric cancer: implications for screening. Gastrointest. Endosc. Clin. N. Am. 7, 47\u201364 (1997).","journal-title":"Gastrointest. Endosc. Clin. N. Am."},{"key":"BFnrgastro2016195_CR122","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0140-6736(96)01501-2","volume":"348","author":"J Parsonnet","year":"1996","unstructured":"Parsonnet, J., Harris, R. A., Hack, H. M. & Owens, D. K. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 348, 150\u2013154 (1996).","journal-title":"Lancet"},{"key":"BFnrgastro2016195_CR123","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1001\/archinte.159.2.142","volume":"159","author":"AM Fendrick","year":"1999","unstructured":"Fendrick, A. M. et al. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch. Intern. Med. 159, 142\u2013148 (1999).","journal-title":"Arch. Intern. Med."},{"key":"BFnrgastro2016195_CR124","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1046\/j.1365-2036.2002.01204.x","volume":"16","author":"J Mason","year":"2002","unstructured":"Mason, J. et al. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomised controlled trial. Aliment. Pharmacol. Ther. 16, 559\u2013568 (2002).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016195_CR125","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1158\/1055-9965.EPI-06-0758","volume":"16","author":"YC Lee","year":"2007","unstructured":"Lee, Y. C. et al. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer. Cancer Epidemiol. Biomarkers Prev. 16, 875\u2013885 (2007).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrgastro2016195_CR126","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ijc.23864","volume":"124","author":"JM Yeh","year":"2009","unstructured":"Yeh, J. M., Kuntz, K. M., Ezzati, M. & Goldie, S. J. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int. J. Cancer 124, 157\u2013166 (2009).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro2016195_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta7060","volume":"7","author":"P Roderick","year":"2003","unstructured":"Roderick, P. et al. The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model. Health Technol. Assess. 7, 1\u201386 (2003).","journal-title":"Health Technol. Assess."},{"key":"BFnrgastro2016195_CR128","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1017\/S0266462307080117","volume":"24","author":"F Xie","year":"2008","unstructured":"Xie, F., Luo, N., Blackhouse, G., Goeree, R. & Lee, H. P. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. Int. J. Technol. Assess. Health Care 24, 87\u201395 (2008).","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"BFnrgastro2016195_CR129","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jacr.2009.01.022","volume":"6","author":"F Xie","year":"2009","unstructured":"Xie, F. et al. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada. J. Am. Coll. Radiol. 6, 317\u2013323 (2009).","journal-title":"J. Am. Coll. Radiol."},{"key":"BFnrgastro2016195_CR130","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(00)02236-4","volume":"355","author":"P Moayyedi","year":"2000","unstructured":"Moayyedi, P. et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 355, 1665\u20131669 (2000).","journal-title":"Lancet"},{"key":"BFnrgastro2016195_CR131","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/j.1365-2036.2007.03500.x","volume":"26","author":"AC Ford","year":"2007","unstructured":"Ford, A. C. et al. Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use. Aliment. Pharmacol. Ther. 26, 1267\u20131275 (2007).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016195_CR132","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1053\/j.gastro.2005.09.016","volume":"129","author":"AC Ford","year":"2005","unstructured":"Ford, A. C., Forman, D., Bailey, A. G., Axon, A. T. R. & Moayyedi, P. A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomised controlled trial. Gastroenterology 129, 1910\u20131917 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016195_CR133","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/bmj.38702.662546.55","volume":"332","author":"JA Lane","year":"2006","unstructured":"Lane, J. A. et al. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol Helicobacter project: randomised controlled trial. BMJ 332, 199\u2013202 (2006).","journal-title":"BMJ"},{"key":"BFnrgastro2016195_CR134","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2036.2010.04363.x","volume":"32","author":"RF Harvey","year":"2010","unstructured":"Harvey, R. F. et al. Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations \u2014 the Bristol Helicobacter Project. Aliment. Pharmacol. Ther. 32, 394\u2013400 (2010).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016195_CR135","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1126\/science.aaf9286","volume":"353","author":"R Laxminarayan","year":"2016","unstructured":"Laxminarayan, R., Sridhar, D., Blaser, M., Wang, M. & Woolhouse, M. Achieving global targets for antimicrobial resistance. Science 353, 874\u2013875 (2016).","journal-title":"Science"},{"key":"BFnrgastro2016195_CR136","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2036.2011.04937.x","volume":"35","author":"JP Gisbert","year":"2012","unstructured":"Gisbert, J. P. & Calvet, X. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. Aliment. Pharmacol. Ther. 35, 209\u2013221 (2012).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016195_CR137","doi-asserted-by":"publisher","first-page":"e59414","DOI":"10.1371\/journal.pone.0059414","volume":"8","author":"FA Sirgel","year":"2013","unstructured":"Sirgel, F. A. et al. The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks. PLoS ONE 8, e59414 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016195_CR138","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/gut.2003.022111","volume":"53","author":"F Megraud","year":"2004","unstructured":"Megraud, F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53, 1374\u20131384 (2004).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR139","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","volume":"62","author":"F Megraud","year":"2013","unstructured":"Megraud, F. et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 62, 34\u201342 (2013).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR140","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1572-0241.1999.00856.x","volume":"94","author":"A Henry","year":"1999","unstructured":"Henry, A. & Batey, R. G. Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the HelP Study. Am. J. Gastroenterol. 94, 811\u2013815 (1999).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016195_CR141","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/gut.41.6.735","volume":"41","author":"JJ Misiewicz","year":"1997","unstructured":"Misiewicz, J. J. et al. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut 41, 735\u2013739 (1997).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR142","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/bmj.324.7349.1306","volume":"324","author":"PD van der Linden","year":"2002","unstructured":"van der Linden, P. D., Sturkenboom, M. C., Herings, R. M., Leufkens, H. G. & Stricker, B. H. Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ 324, 1306\u20131307 (2002).","journal-title":"BMJ"},{"key":"BFnrgastro2016195_CR143","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0168-8278(01)00082-4","volume":"35","author":"L Spahr","year":"2001","unstructured":"Spahr, L., Rubbia-Brandt, L., Marinescu, O., Armenian, B. & Hadengue, A. Acute fatal hepatitis related to levofloxacin. J. Hepatol. 35, 308\u2013309 (2001).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016195_CR144","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.clpt.2003.08.008","volume":"74","author":"G Apseloff","year":"2003","unstructured":"Apseloff, G. Severe neutropenia among healthy volunteers given rifabutin in clinical trials. Clin. Pharmacol. Ther. 74, 591\u2013592 (2003).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BFnrgastro2016195_CR145","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0161-6420(00)00586-8","volume":"108","author":"N Bhagat","year":"2001","unstructured":"Bhagat, N., Read, R. W., Rao, N. A., Smith, R. E. & Chong, L. P. Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals. Ophthalmology 108, 750\u2013752 (2001).","journal-title":"Ophthalmology"},{"key":"BFnrgastro2016195_CR146","doi-asserted-by":"publisher","first-page":"e0151893","DOI":"10.1371\/journal.pone.0151893","volume":"11","author":"TW Yap","year":"2016","unstructured":"Yap, T. W. et al. Helicobacter pylori eradication causes perturbation of the human gut microbiome in young adults. PLoS ONE 11, e0151893 (2016).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016195_CR147","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/gutjnl-2015-309197","volume":"65","author":"KF Pan","year":"2016","unstructured":"Pan, K. F. et al. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut 65, 9\u201318 (2016).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR148","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1136\/bmj.328.7453.1417","volume":"328","author":"RF Harvey","year":"2004","unstructured":"Harvey, R. F. et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol Helicobacter project. BMJ 328, 1417\u20131420 (2004).","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"BFnrgastro2016195_CR149","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1136\/gut.43.2008.S33","volume":"43","author":"D Forman","year":"1998","unstructured":"Forman, D. Helicobacter pylori: the gastric cancer problem. Gut 43 (Suppl. 1), S33\u2013S34 (1998).","journal-title":"Gut"},{"key":"BFnrgastro2016195_CR150","unstructured":"PMLive. Product updates from Japan. PMLive http:\/\/www.pmlive.com\/pharma_news\/product_updates_from_japan_464695 (2013)."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2016.195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2016.195","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2016.195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:55:46Z","timestamp":1684468546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":150,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFnrgastro2016195"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2016.195","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]},"assertion":[{"value":"5 January 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}